The disease burden in Inflammatory Bowel Disease is significant in the US and Europe. Imaging modalities including CT, MRI and Ultrasound have similar sensitivity and specificity with IBD diagnosis. While the advantages of CT scans include greater accessibility, lower cost, and better spatial resolution, its major disadvantage is ionizing radiation, in which cumulative doses directly increase the risk of malignancy. On the other hand, ultrasound and MRI do not impart ionizing radiation. Ultrasound allows for evaluation of the gastrointestinal tract but is time intensive and operator/patient dependent. MRI provides improved soft tissue resolution, but is costly, time-consuming and has inferior spatial resolution compared to CT. Aims: With growing evidence of radiation-related neoplasms, the literature has been sparse in examining changes in imaging utilization. This study examines imaging trends in IBD patients. Methods: A provincial (Ontario) database of 72 933 IBD patients (CD 34 448 and UC 38 485) and 729 330 matched controls were examined from 1999-2016. Quarterly rates of CT abdomen/pelvis, MRI, and ultrasound per patient were examined over this period. The absolute and relative change in imaging utilization was examined.
1.46x, and 1.58x increase for CD, UC, and non-IBD patients respectively. Conclusions: At the beginning of the study, CD and UC patients had a higher utilization of CT abdomen/pelvis per quarter, but non-IBD patients had a higher utilization of ultrasound. At the end of the study, the absolute rate of CT abdomen/pelvis utilization per patient was higher than MRI and ultrasound in all groups. All imaging modalities were utilized at a higher rate at the end of the study. The most marked increase in imaging utilization was in MR abdomen in all groups, with a 31.41x, 78.13x, and 23.38x increase for CD, UC and non-IBD patients, respectively.
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